Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

BETA BIOSCIENCES, LLC

NPI: 1245692169 · KANSAS CITY, MO 64118 · Clinical Medical Laboratory · NPI assigned 03/22/2016

$55K
Total Medicaid Paid
5,325
Total Claims
3,258
Beneficiaries
35
Codes Billed
2020-08
First Month
2024-05
Last Month

Provider Details

Authorized OfficialGRAY, KEITH (MANAGING PARTNER)
NPI Enumeration Date03/22/2016

Related Entities

Other providers sharing the same authorized official: GRAY, KEITH

ProviderCityStateTotal Paid
AXIS PROFESSIONAL LABS LLC FARMERS BRANCH TX $459K
LEANNAH INVESTMENT PARTNERS, LTD FRISCO TX $264K
KINGDOM HEALTH LABORATORY LLC DALLAS TX $19K
GLOBAL REACH LABS, LLC DENVER CO $408.00

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2020 738 $31K
2021 4,127 $23K
2024 460 $1K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2,054 1,262 $48K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1,347 710 $3K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 261 214 $3K
82610 25 24 $155.60
86800 25 24 $120.24
82670 12 12 $117.35
80061 Lipid panel 26 25 $112.50
84466 25 24 $107.20
83036 Hemoglobin; glycosylated (A1C) 26 25 $73.44
84481 13 13 $71.15
82607 13 13 $63.35
82746 12 12 $61.75
86376 12 12 $61.10
82977 25 24 $60.50
86141 14 13 $54.40
84443 Thyroid stimulating hormone (TSH) 12 12 $53.76
80053 Comprehensive metabolic panel 15 15 $50.64
85025 Blood count; complete (CBC), automated, and automated differential WBC count 16 16 $43.47
82172 25 24 $35.44
85045 25 24 $33.50
83690 14 13 $28.95
84436 12 12 $28.85
83735 14 13 $28.15
82150 14 13 $27.20
84479 13 13 $27.15
83540 14 13 $27.15
83615 14 13 $25.35
86431 14 13 $23.80
82248 14 13 $21.10
84100 14 13 $19.90
84550 14 13 $19.00
G2024 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source 1,040 478 $0.00
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 31 28 $0.00
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 60 56 $0.00
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 60 56 $0.00